Description: This paper addresses controversies related to Zillmer Reserves first proposed in the 1860's and discusses how actuaries can learn form these dilemmas and find a review of the controversy useful in more current practice. The paper was presented at the 25th Actuarial Research Conference held at the University of Western Ontario in 1990. From Actuarial Research Clearing House 1991, VOL. 1.

Description: Presented at May 1986 Spring Meeting. This session discussion is about redetermination of 'Non-Guaranteed Pricing Elements Recommendations', actuarial responsibilities to the various publics relative to nonguaranteed pricing functions and brief status report on Interim Actuarial Standards Board 'IASB' including how this Committee's Exposure Draft affects the IASB.

Description: Breakout Sessions 1A: The Fundamentals of Pricing for Underwriters

Description: This session will cover lessons learned during the course of implementing PBR by the panelists. It will focus on areas that were difficult to interpret, unexpected issues and managing the process. It will focus on potential stumbling blocks from an implementation, pricing and product development standpoint. There will also be an overview of YRT treatment to date and an update on any emerging best practices.

Description: This research report examines the ban of the use of genetic testing information in life insurance mortality.

Description: The Canadian Institute of Actuaries (CIA) and the Society of Actuaries (SOA) engaged RGA Reinsurance Company (RGA) to undertake a research project on Canadian level premium term life insurance products with a particular focus on the magnitude and impact of the “shock lapse” at the end of the level premium period. This project is similar to the SOA-sponsored research completed by RGA for U.S. term plans in 2010 and updated September 2013 and May 2014.

Description: As results emerged showing the influence of COVID-19 on recent mortality, the Society of Actuaries Research Institute’s Mortality and Longevity Strategic Research Program Steering Committee (MLPSC) began to ponder what it means for the future. Was the coronavirus pandemic just a temporary shock to U.S. mortality with mortality quickly returning to prepandemic levels upon its conclusion or a lingering factor in future U.S. mortality from the potential occurrence of new coronavirus variants, post-COVID-19 conditions (“long COVID”), deferral of needed health care treatment, a fatigued health care system and other elements? Only time will provide the answers to these questions.

Description: A literature review was performed on mortality improvement, socioeconomic differences in mortality and their links to specific causes of death, and methods for analysis. It highlighted the fact that socioeconomic status (e.g., income and education) is closely linked to differences in mortality and that the longevity gap between socioeconomic groups is growing over time. It also informed the selection of key variables and the need to view mortality improvement as a complex interaction between specific causes of death.

Description: The SOA’s Committee on Life Insurance Company Expenses (CLICE) has submitted its recommendation for the 2024 Generally Recognized Expense Table (GRET) for use with individual life insurance sales illustrations. The recommendation is currently being exposed for comments by the NAIC for 30 days until September 12, 2023.

Description: FASB's Statement of Financial Accounting Standards No. 97 contains wide-sweeping changes to the preparation of GAAP financials for insurance companies. The focus of this article will be on the ramifications of the interest rate FASB has decided to use to amortize deferred acquisition costs.